What does PMV Pharmaceuticals, Inc. do?

Jun 22 2025 06:51 PM IST
share
Share Via
PMV Pharmaceuticals, Inc. is a precision oncology company developing small molecule therapies targeting p53 mutations. It has a market cap of $56.63 million and reported a net profit loss of $17 million as of March 2025.
Overview:
PMV Pharmaceuticals, Inc. is a precision oncology company focused on discovering and developing small molecule, tumor-agnostic therapies targeting p53 mutations, operating within the Miscellaneous industry and classified as a micro-cap company. Financial Snapshot: Most recent Net Profit: -17 Million (Quarterly Results - Mar 2025) Market cap: USD 56.63 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.00 Return on Equity: -38.02% Price to Book: 0.35 Contact Details: Address: 8 Clarke Drive, CRANBURY NJ: 08512 Tel: 1 609 6426664 Fax: 1 302 6365454 Website: http://pmvpharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is PMV Pharmaceuticals, Inc.?
Jun 22 2025 06:07 PM IST
share
Share Via